Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Natrol

This article was originally published in The Tan Sheet

Executive Summary

Company is shipping CholesteSure red yeast rice extract to food, drug and mass market outlets, as well as health food stores nationwide. Full distribution is expected within a month. A 60-count bottle will sell for $14.99. Each 600 mg capsule contains .4% lovastatin, the same active ingredient in Simi Valley, Calif.-based Pharmanex' Cholestin and Merck's Rx cholesterol reducer, Mevacor. Labeling for CholesteSure contains the structure/function claim "Promotes balanced cholesterol levels." Pharmanex filed suit against Trevose, Penn.-based HPF, Inc. April 14 related to the company's marketing of its red yeast rice product, Cholestene. The suit is pending
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS089930

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel